Companies: 10,795·Total market cap: $144.5T
Ascentage Pharma Group International

Ascentage Pharma Group International

AAPGNASDAQHealthcare● Active
$17.48
+$0.28(+1.63%)
Market Cap$1.6B
P/E Ratio—
52W High$48.45
52W Low$16.95
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Ascentage Pharma Group International (AAPG) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0002023311 · AAPG · NASDAQ · as of Jun 8, 2026

Filing snapshot

113
Total Filings
6-K
Latest Form
2026-06-01
Most Recent
2025
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0002023311 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-04-29
Fiscal Year End
Apr 29, 2026
Accession No.
0001213900-26-049412
Primary Document
ea0285148-20f_ascentage.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0002023311 · Accession 0001213900-26-049412

Latest Key Filings

6-KQuarterly Report
REPORT OF FOREIGN PRIVATE ISSUER
2026-06-01
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-06-01
View
6-KCurrent Report (Foreign Issuer)
CURRENT REPORT
2026-05-28
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-28
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-22
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-13
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-12
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-05-01
View
20-FAnnual Report (Foreign Issuer)
ANNUAL REPORT
2026-04-29
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-22
View
3Initial Statement of Beneficial Ownership
PRIMARY DOCUMENT
2026-04-21
View
3/AInitial Statement of Beneficial Ownership (Amended)
PRIMARY DOCUMENT
2026-04-20
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-20
View
3Initial Statement of Beneficial Ownership
PRIMARY DOCUMENT
2026-04-10
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-04-01
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER
2026-03-26
View
Showing 1–15 of 110 filingsForm 4 / 144 hidden· 113 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0002023311  |  Exchange: NASDAQ · Healthcare

Ascentage Pharma Group International (NASDAQ: AAPG) has submitted 113 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2025. As a Healthcare sector company with CIK 0002023311, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Ascentage Pharma Group International's most comprehensive regulatory disclosure. The most recent Ascentage Pharma Group International 10-K was filed on 2026-04-29 for fiscal year ending 2026. Historical AAPG 10-K annual reports are available from 2024 through 2026.

Investors researching Ascentage Pharma Group International SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
CNTA SEC Filings →LEGN SEC Filings →APGE SEC Filings →CGON SEC Filings →CELC SEC Filings →XENE SEC Filings →SLNO SEC Filings →IRON SEC Filings →
→ AAPG Financials→ AAPG Earnings→ AAPG Insider Trades

Frequently Asked Questions

AAPG SEC Filings · 8 questions

Ascentage Pharma Group International (AAPG) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 113 filings and access original documents at no cost. Ascentage Pharma Group International's CIK is 0002023311.

AAPG SEC filingsAscentage Pharma Group International SEC documentsfind AAPG 10-K